Patupilone (epothilone B, EPO906) and imatinib (STI571, Glivec) in combination display enhanced antitumour activity in vivo against experimental rat C6 glioma T. O’ReillyM. WartmannP. M. J. McSheehy Original Article 26 October 2004 Pages: 307 - 317
Isolated pelvic perfusion: plasma pharmacokinetics depend primarily on drug dosage and not the type of drug James F. BelliveauElisabeth ArevaloHarold J. Wanebo Original Article 15 January 2005 Pages: 318 - 322
A possible mechanism for the long-lasting antitumor effect of the macromolecular conjugate DE-310: mediation by cellular uptake and drug release of its active camptothecin analog DX-8951 Yusuke OchiYoshinobu ShioseEiji Kumazawa Original Article 26 October 2004 Pages: 323 - 332
Role of glutathione and nucleotide excision repair in modulation of cisplatin activity with O6-benzylguanine Melissa L. FishelMichael P. GamcsikM. Eileen Dolan Original Article 02 October 2004 Pages: 333 - 342
Endometrial K-ras mutations in postmenopausal breast cancer patients treated with adjuvant tamoxifen or toremifene Mika WallénEija TomásJohanna Mäenpää Original Article 20 November 2004 Pages: 343 - 346
Interactions of carboxypeptidase G2 with 6S-leucovorin and 6R-leucovorin in vitro: implications for the application in case of methotrexate intoxications Georg HempelRainer LinggJoachim Boos Original Article 21 October 2004 Pages: 347 - 353
Phase I study of weekly (day 1 and 8) docetaxel in combination with capecitabine in patients with advanced solid malignancies Ramesh K. RamanathanSakkaraiappan RamalingamWilliam C. Zamboni Original Article 27 October 2004 Pages: 354 - 360
Biochemical modulation of cytarabine triphosphate by clofarabine Todd CooperMary AyresVarsha Gandhi Original Article 16 October 2004 Pages: 361 - 368
RETRACTED ARTICLE: Quinoxaline 1,4-dioxides induce G2/M cell cycle arrest and apoptosis in human colon cancer cells Hala U. Gali-MuhtasibMona Diab-AssafMakhluf J. Haddadin Original Article 05 November 2004 Pages: 369 - 378
Imatinib pharmacokinetics in patients with gastrointestinal stromal tumour: a retrospective population pharmacokinetic study over time. EORTC Soft Tissue and Bone Sarcoma Group Ian JudsonPeiming MaAllan van Oosterom Original Article 09 December 2004 Pages: 379 - 386
Does cisplatin (CDDP) function as a modulator of 5-fluorouracil (5-FU) antitumor action? A study based on a clinical trial Satoshi MatsusakaTomofumi NagaredaHajime Yamasaki Original Article 13 January 2005 Pages: 387 - 392
Gefitinib (“Iressa”, ZD1839) inhibits SN38-triggered EGF signals and IL-8 production in gastric cancer cells Osamu KishidaYoshiji MiyazakiYasuhisa Shinomura Original Article 05 October 2004 Pages: 393 - 403
Bioavailability and pharmacokinetics of the investigational anticancer agent XK469 (NSC 698215) in rats following oral and intravenous administration Ramesh R. BoinpallySen-Lin ZhouRalph E. Parchment Short Communication 09 December 2004 Pages: 404 - 407